Introduction to Dyslipidemia and Lipid Metabolism
24 Questions
1 Views

Choose a study mode

Play Quiz
Study Flashcards
Spaced Repetition

Podcast

Play an AI-generated podcast conversation about this lesson

Questions and Answers

Which of the following is NOT a risk factor for developing rhabdomyolysis when taking statins?

  • Use of certain medications
  • Small body frame and frailty
  • Moderate physical exercise (correct)
  • Chronic kidney disease
  • What is the average percentage reduction in LDL cholesterol achieved by Ezetimibe?

  • 30%
  • 18% (correct)
  • 12%
  • 25%
  • Which of the following medications can increase the risk of myopathy when taken with statins?

  • Fibrates (correct)
  • Beta blockers
  • Antihistamines
  • Aspirin
  • In what percentage of patients are adverse side effects leading to discontinuation of statin therapy reported?

    <p>Less than 4%</p> Signup and view all the answers

    What is defined as muscle symptoms with marked elevation in CK at 50 times the upper limit of normal?

    <p>Rhabdomyolysis</p> Signup and view all the answers

    What additional effect does Ezetimibe have on HDL cholesterol levels?

    <p>Modestly increases it</p> Signup and view all the answers

    Which of the following is LEAST likely to be an adverse effect associated with statins?

    <p>Severe gastrointestinal distress</p> Signup and view all the answers

    When should pharmacological therapy be considered for patients needing primary prevention?

    <p>After 3 to 6 months if goals are not met</p> Signup and view all the answers

    What percentage range of triglyceride reduction can niacin achieve?

    <p>11% to 60%</p> Signup and view all the answers

    Which niacin formulation is specifically designed to reduce flushing without increasing hepatotoxicity risk?

    <p>Extended-release (ER)</p> Signup and view all the answers

    Which of the following is a primary effect of fibrates?

    <p>Decrease triglyceride levels</p> Signup and view all the answers

    What is the maximum recommended daily dose for extended-release niacin?

    <p>2 g</p> Signup and view all the answers

    Which statin-related concern is associated with fibrates?

    <p>Higher risk of myopathy with fenofibrate</p> Signup and view all the answers

    What complication could arise due to fibrate therapy?

    <p>Gallbladder disorders</p> Signup and view all the answers

    How long does it typically take to see maximum lipid effects when using niacin?

    <p>3 to 5 weeks</p> Signup and view all the answers

    What is a major limitation of using immediate-release niacin?

    <p>Flushing</p> Signup and view all the answers

    What is the primary benefit of using ezetimibe in patients who do not adequately respond to statin therapy?

    <p>It lowers LDL levels by increasing the number of LDL receptors.</p> Signup and view all the answers

    What should patients be advised to do to prevent constipation while taking bile acid sequestrants?

    <p>Increase fluid intake.</p> Signup and view all the answers

    What is a common adverse effect of statin therapy that a patient should be monitored for?

    <p>Myopathy</p> Signup and view all the answers

    Which of the following drugs is most likely to be affected by bile acid sequestrants when taken concurrently?

    <p>Warfarin</p> Signup and view all the answers

    What is the time frame for achieving maximum lipid-lowering effects from resins?

    <p>2 to 4 weeks</p> Signup and view all the answers

    How do PCSK9 inhibitors lower LDL cholesterol levels?

    <p>By binding to and inhibiting PCSK9, enhancing LDL receptor availability.</p> Signup and view all the answers

    What is a unique characteristic of colesevelam compared to other bile acid sequestrants?

    <p>It is better tolerated with fewer gastrointestinal side effects.</p> Signup and view all the answers

    What effect do bile acid sequestrants have on triglyceride levels?

    <p>They increase triglyceride levels in some patients.</p> Signup and view all the answers

    Study Notes

    Introduction to Dyslipidemia

    • Dyslipidemia is elevated total cholesterol, low-density lipoprotein (LDL) cholesterol, or triglycerides, or a low high-density lipoprotein (HDL) cholesterol
    • These abnormalities can lead to coronary, cerebrovascular, and peripheral vascular arterial disease

    Lipid Transport and Metabolism

    • Cholesterol is a crucial substance made by the body's cells
    • It maintains cell structure, aids in bile acid and hormone production
    • Triglycerides and phospholipids are also essential lipids
    • Lipoproteins (lipid-protein complexes) transport these lipids in the bloodstream

    Lipoprotein Classification

    • Lipoproteins vary in size and density based on lipid and protein content
    • Chylomicrons, VLDL, IDL, LDL, and HDL are different lipoprotein classes
    • Their size and density affect their movement during centrifugation
    • Lipoproteins are classified by their density: Chylomicrons, VLDL, IDL, LDL, and HDL

    Familial Dyslipidemia Types

    • Different types of familial dyslipidemia exist, each with distinct characteristics
    • Type I: Hyperchylomicronemia (elevated chylomicrons and triglycerides)
    • Type IIa: Hypercholesterolemia (elevated LDL cholesterol)
    • Type IIb: Combined hyperlipidemia (elevated both LDL and triglycerides)
    • Type III: Dysbetalipoproteinemia (elevated IDL remnants)
    • Type IV: Hypertriglyceridemia (elevated triglycerides)
    • Type V: Mixed hypertriglyceridemia (elevated both triglycerides and cholesterol)

    Clinical Presentation and Diagnosis

    • Dyslipidemia often asymptomatic, but corneal arcus and xanthomas might be seen in patients
    • Extreme elevations of LDL or triglycerides lead to pancreatitis or tuberoeruptive xanthomas
    • Lipid profiles (total cholesterol, non-HDL, LDL, HDL cholesterol, triglycerides) are essential screenings for all adults over 20 every 5 years.
    • Children with high cholesterol risk factors should be screened too

    Indications for Additional Tests

    • Tests should be used for conditions that may create lipid irregularities
    • Conditions like those in Table 12-2 (specific examples not included in the summary) should be screened

    National Lipid Association Classifications

    • National Lipid Association provides cholesterol and triglyceride classification levels (in mg/dL and mmol/L). Specific LDL, HDL, total cholesterol ranges are listed.
    • Classification is essential for determining risk levels and treatments.

    Treatment

    • Lifestyle modifications (diet, exercise, weight reduction) are first-line therapies
    • These changes should include reducing total fat to 30% of total energy intake, saturated fat to 10% and cholesterol to 300mg daily and increasing fruits, vegetables, fiber, and fish oil intake.
    • Medications are considered for high-risk patients or those who do not achieve desired results from lifestyle modifications

    Statins

    • Statins are widely used lipid-lowering medications.
    • Adverse effects listed can include liver problems, muscle weakness, and rare cases of rhabdomyolysis
    • Monitoring of liver function tests and creatine kinase levels is important

    Cholesterol Absorption Inhibitors

    • Ezetimibe reduces LDL cholesterol but can also result in some increase in HDL levels and a slight decrease in triglycerides
    • Ezetimibe is primarily used when statin treatment doesn't bring adequate reduction in cholesterol

    Bile Acid Sequestrants

    • These medications bind to bile acids in the gut, causing these acids to be excreted and resulting in increased LDL receptors and reduced serum cholesterol

    Niacin

    • Niacin (vitamin B3) is used for lower LDL cholesterol and increased HDL.
    • Potential for significant flushing and liver issues.
    • Extended-release niacin is better tolerated

    Fibrates

    • Fibrates primarily lower triglycerides and raise HDL levels.
    • Gemfibrozil is a less preferred fibrate when combined with statin for fear of affecting the statin glucuronidation
    • Monitoring of liver function tests and creatine kinase levels is essential

    Omega-3 Fatty Acids

    • Omega-3 fatty acids reduce triglycerides and may have additional cardiovascular benefits.Excessive consumption can be problematic for patients on anticoagulants and/or antiplatelets

    Studying That Suits You

    Use AI to generate personalized quizzes and flashcards to suit your learning preferences.

    Quiz Team

    Related Documents

    Description

    This quiz covers the fundamentals of dyslipidemia, lipid transport, and metabolism, including key concepts such as cholesterol's role in the body and lipoprotein classification. Test your knowledge on the types of dyslipidemia and their implications for cardiovascular health.

    More Like This

    Use Quizgecko on...
    Browser
    Browser